In active shopping mode, Eli Lilly plots one deal per quarter as it scouts 'Dermira-like' assets up to $5B
By delivering the only M&A news in a relatively muted deal scene at JP Morgan, Eli Lilly distinguished itself as an active buyer right at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.